Pinpoint Asset Management LTD Alnylam Pharmaceuticals, Inc. Transaction History

Pinpoint Asset Management LTD

  • $506 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$169.75 - $207.73 $2.22 Million - $2.72 Million
-13,100 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$128.63 - $176.89 $527,383 - $725,249
4,100 Added 45.56%
13,100 $2.22 Million
Q1 2021

May 13, 2021
BUY
$126.83 - $175.69 $1.14 Million - $1.58 Million
9,000 New
9,000 $1.27 Million

Others Institutions Holding ALNY

# of Institutions
638
Shares Held
107M
Call Options Held
2.33M
Put Options Held
2.15M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $32.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Pinpoint Asset Management LTD Portfolio

Follow Pinpoint Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinpoint Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinpoint Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email